- Pharmaceutical companies
- Octapharma
Octapharma
Phone: +4141 55 4512121
Fax: 41 55 4512110
E-mail: Via Site
Web: https://www.octapharma.com
| Type | Private |
|---|---|
| Industry | Pharmaceutical industry |
| Founded | 1983 |
| Headquarters | Lachen, Switzerland |
| Number of locations | 31 |
| Products | octanate; octanine-F; wilate; Nuwiq; octagam; gammanorm; rhesonativ; panzyga; albunorm; octaplas; atenativ; octaplex; octaplasLG; fibryga See complete products listing. |
| Revenue | Euro 2.4 billion (2020) |
| Number of employees | 9,067(2020) |
| Website | www.octapharma.com |
Our five values -Ownership, Integrity, Leadership, Sustainability and Entrepreneurship- guide our patient-oriented corporate culture. We aspire to embody these values in everything we do. We are the largest privately owned and independent plasma fractionator in the world. Our medicines are high-quality human proteins sourced from human plasma and human cell lines. Family-owned since being established in 1983, Octapharma is a global healthcare company headquartered in Lachen, Switzerland. Our products are available in 118 countries and reach hundreds of thousands of patients every year. We focus on three therapeutic areas: haematology, immunotherapy and critical care. Octapharma is one of the largest human protein product manufacturers. We develop and produce medicines based on human proteins from human cell lines and human plasma, sourced from our own plasma donation centres and other external sources.
For detailed contact information visit location pages below.
Octapharma's locations around the world
Clinical Trials sponsored by Octapharma
-
OctapharmaRecruitingAcute Hereditary Angio EdemaUkraine, United States, Mexico, Bulgaria, Serbia, Armenia, Montenegro, Turkey (Türkiye), Albania, Argentina, Peru, Romania
-
OctapharmaRecruitingHemophilia ASpain, United States, United Kingdom, Germany, France, Serbia, Finland, Italy, Switzerland, Uruguay
-
OctapharmaRecruitingAcute Major BleedingSpain, Germany, Georgia, United States, Croatia, Italy, Poland, Ukraine, Bosnia and Herzegovina, France, Austria, United Kingdom, Turkey (Türkiye)
-
OctapharmaActive, not recruitingPrimary Immune DeficiencyUnited States, Hungary, Poland, Italy, Germany, Slovakia, Ukraine
-
OctapharmaCompletedVon Willebrand DiseaseUnited States, Czechia, Germany, North Macedonia, Ukraine, Moldova, Russia
-
OctapharmaTerminatedCongenital Fibrinogen DeficiencyCzechia, Germany
-
OctapharmaTerminated
-
OctapharmaCompletedVon Willebrand DiseasesLebanon, Croatia, United States, Belarus, Bulgaria, Hungary, Russian Federation, Ukraine
-
OctapharmaCompletedReversal of Anticoagulant TreatmentUnited States
-
OctapharmaCompletedSevere Hemophilia ACanada, United States, France, Spain, Ukraine, United Kingdom, Belarus, Georgia, Germany, India, Italy, Moldova, Republic of, Morocco, Poland, Portugal, Russian Federation, Slovenia